Cannabis Suisse (CSUI) EBITDA Margin (2016 - 2025)
Historic EBITDA Margin for Cannabis Suisse (CSUI) over the last 8 years, with Q1 2025 value amounting to 876.36%.
- Cannabis Suisse's EBITDA Margin fell 523600.0% to 876.36% in Q1 2025 from the same period last year, while for Nov 2025 it was 3681.81%, marking a year-over-year decrease of 26534100.0%. This contributed to the annual value of 1261.2% for FY2025, which is 4188900.0% down from last year.
- Latest data reveals that Cannabis Suisse reported EBITDA Margin of 876.36% as of Q1 2025, which was down 523600.0% from 1216.64% recorded in Q4 2024.
- Over the past 5 years, Cannabis Suisse's EBITDA Margin peaked at 524.7% during Q4 2021, and registered a low of 6199.64% during Q1 2023.
- Moreover, its 4-year median value for EBITDA Margin was 851.61% (2023), whereas its average is 1399.72%.
- As far as peak fluctuations go, Cannabis Suisse's EBITDA Margin crashed by -13943600bps in 2021, and later soared by 53756400bps in 2024.
- Over the past 4 years, Cannabis Suisse's EBITDA Margin (Quarter) stood at 524.7% in 2021, then fell by -26bps to 661.88% in 2023, then plummeted by -84bps to 1216.64% in 2024, then rose by 28bps to 876.36% in 2025.
- Its EBITDA Margin was 876.36% in Q1 2025, compared to 1216.64% in Q4 2024 and 983.71% in Q3 2024.